WelChol

This page contains recent news articles, when available, and an overview of WelChol but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

Daiichi Sankyo product receives FDA approval for cholesterol-lowering drug  -  ‎Nov 12, 2009‎
Daiichi Sankyo has announced that its drug Welchol has been granted approval by the Food and Drug Administration (FDA) for use in heterozygous familial ... Zenopa

Daiichi Sankyo says FDA OKs Welchol for diabetes treatment  -  Jan 19, 2008
Jan 18 (Reuters) - Daiichi Sankyo Inc, the US subsidiary of Japan's Daiichi Sankyo Co Ltd (4568.T: Quote, Profile, Research), said US health regulators ... Reuters India

Daiichi Sankyo says FDA OKs Welchol for diabetes treatment  -  Jan 18, 2008
Jan 18 (Reuters) - Daiichi Sankyo Inc, the US subsidiary of Japan's Daiichi Sankyo Co Ltd (4568.T), said US health regulators approved its cholesterol drug ... Reuters

… Of Supplemental New Drug Application For WelChol In The Treatment...  -  Jan 3, 2007
If approved, WelChol will be the first LDL cholesterol lowering medication ... Clinical studies have shown that WelChol lowers A1C in patients with type 2 ... Medical News Today - Medical News Today (press release)

WelChol and Ezetimibe Combination Therapy Provides Significant LDL-C …  -  Nov 13, 2006
A new study found that taking WelChol(R) (colesevelam HCI) in combination with ezetimibe reduced LDL-C by 32%, reducing mean LDL-C levels by an additional ... RedOrbit

… Finds Additional LDL-C Drops When WelChol (Colesevelam HCl) is …  -  Oct 5, 2005
PARSIPPANY, NJ -- October 5, 2005 -- A new study published in the September 2005 issue of Current Medical Research and Opinion demonstrated that the ... DG News

… Show Addition of a Bile Acid Sequestrant (WelChol, colesevelam...  -  Apr 18, 2006
This is the first data to demonstrate that WelChol, a bile acid sequestrant (BAS), ... The pooled study results also demonstrated that WelChol plus a statin ... DG News

… From Pooled Analyses Demonstrates Welchol, Combined With Metformin...  -  May 16, 2008
PARSIPPANY, NJ--(Marketwire - May 16, 2008) - Daiichi Sankyo, Inc. (DSI) announced today that data from two pooled analyses further demonstrate that ... marketwire.com

Addition Of A Bile Acid Sequestrant (WelChol, Colesevelam HCl) To …  -  Apr 19, 2006
Data published today in the April 15 issue of the American Journal of Cardiology demonstrated that adding WelChol(R) (colesevelam hydrochloride) to stable ... Medical News Today - Medical News Today (press release)

Daiichi Sankyo, Inc. Announces Filing for WelChol Label Change to …  -  Mar 28, 2007
Daiichi Sankyo, Inc. announced today that it has filed for a label change with the US Food and Drug Administration to include ezetimibe efficacy data from a ... RedOrbit

New Study Confirms WelChol Improves Glycemic Control in Patients With...  -  Nov 15, 2006
PARSIPPANY, NJ, Nov. 15 /PRNewswire/ -- Data presented today at the American Heart Association's (AHA) Scientific Sessions 2006 in Chicago demonstrated that ... Free with registration - PR Newswire - AccessMyLibrary.com

… Study Finds Additional LDL-C Drops When WelChol(R) (colesevelam HCl...  -  Oct 5, 2005
New Study Finds Additional LDL-C Drops When WelChol(R) (colesevelam HCl) is Added to Fenofibrate in Patients with Mixed Hyperlipidemia. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research

Welchol TM Added to the American College of Endocrinology/American …  -  Apr 15, 2008
PARSIPPANY, NJ--(Marketwire - April 15, 2008) - Daiichi Sankyo announced today that Welcholâ„¢ (colesevelam HCl) has been added to the American College of ... marketwire.com

Daiichi Sankyo submits sNDA for WelChol.(Daiichi Sankyo)(Brief...  -  Jan 15, 2007
Japanese drug major Daiichi Sankyo has filed a supplemental New Drug Application with the US Food and Drug Administration for WelChol (colesevelam HCl) as a ... Free with registration - Pharma Marketletter - AccessMyLibrary.com

Welchol TM Lowered A1C by a Mean 1 Percent or Greater When Added …  -  May 30, 2008
PARSIPPANY, NJ--(Marketwire - May 30, 2008) - Daiichi Sankyo, Inc., announced today that data from post-hoc analyses of three pivotal studies demonstrated ... marketwire.com

WelChol.(Drug overview)  -  Dec 1, 2005
WelChol is used to lower blood cholesterol levels when diet and exercise prove insufficient. It works by binding with cholesterol-based bile acids to take ... Free with registration - PDR Family Guide to Prescription Drugs - AccessMyLibrary.com

… : Daiichi Sankyo, Inc. Announces Filing For WelChol Label Change to...  -  Mar 28, 2007
Daiichi Sankyo, Inc. Announces Filing For WelChol Label Change to Include Ezetimibe Efficacy Data. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research

Press Release: Welchol(TM) (colesevelam HCl) Receives FDA Approval …  -  Jan 18, 2008
Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults with Type 2 Diabetes. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research

Press Release: WelChol and Ezetimibe Combination Therapy Provides …  -  Nov 13, 2006
WelChol and Ezetimibe Combination Therapy Provides Significant LDL-C Reductions. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research

Press Release: Welchol(TM) Added to the American College of …  -  Apr 15, 2008
Welchol(TM) Added to the American College of Endocrinology/American Association of Clinical Endocrinologists 'Road Maps to Achieve Glycemic Control in ... Pay-Per-View - PR Newswire - HighBeam Research

… Release: First Study to Evaluate WelChol/Ezetimibe and Simvastatin...  -  Nov 13, 2006
First Study to Evaluate WelChol/Ezetimibe and Simvastatin Effect on LDL-C Finds Additional Lipid Parameter Benefits. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research

… to show addition of a bile acid sequestrant (WelChol, colesevelam...  -  Nov 15, 2005
This is the first data to demonstrate that WelChol, a bile acid sequestrant (BAS), ... The pooled study results also demonstrated that WelChol plus a statin ... Pay-Per-View - Company Reports - Factiva, from Dow Jones

New Survey Reveals Many Adults With High Cholesterol Fail to Take …  -  Sep 4, 2007
The branded leader of that class, WelChol®, is an effective option with a ... 3) WelChol differs from many other LDL cholesterol-lowering medications on the ... marketwire.com

… from Pooled Analyses Demonstrates Welchol, Combined with Metformin...  -  May 16, 2008
Data from Pooled Analyses Demonstrates Welchol, Combined with Metformin- or Sulfonylurea-Based Therapy, Significantly Lowers Blood Glucose in Adults with ... Pay-Per-View - PR Newswire - HighBeam Research

Daiichi Sankyo's WelChol Demonstrates Glucose-Lowering Effect  -  Jun 12, 2006
Daiichi Sankyo has presented the first data to show that its cholesterol-lowering drug WelChol also has a glucose-lowering effect. ... RedOrbit

Colesevelam (WelChol) for reduction of LDL cholesterol.(STEPS: New …  -  Jul 15, 2005
Synopsis Safety The risk of systemic toxicity is low because colesevelam is not absorbed. Doses in excess of 4.5 g per day have not been tested. $4.95 - American Family Physician - ECNext

Colesevelam (WelChol) for reduction of LDL cholesterol.(STEPS: New …  -  Jul 15, 2005
Colesevelam (WelChol) is a nonabsorbed binder of bile acids in the intestine, and thereby impedes ... WelChol tablets (colesevelam hydrochloride) Sankyo. ... Pay-Per-View - American Family Physician - Factiva, from Dow Jones

First Clinical Trial to Demonstrate Colesevelam HCl Plus Stable Oral ...  -  Jun 10, 2006
WelChol treatment resulted in a mean 0.5% reduction in A1C versus placebo (p=0.007). Moreover, in patients with A1C greater than or equal to 8.0%, WelChol ... Free with registration - PR Newswire - AccessMyLibrary.com

… Relating To "reddened belly just began welchol along with other...  -  May 10, 2008
...itchy skin, reddened belly; just began welchol along with other med following aertiogram, now what? itchy skin, reddened belly; just began welchol along ... HealthCentral.com

1st Clinical Trial To Show Colesevelam HCl Plus Stable Oral Antidiabet...  -  Jun 26, 2006
The first data to demonstrate the effect of WelChol(R) (colesevelam ... WelChol treatment resulted in a mean 0.5% reduction in A1C versus placebo (p=0.007). ... Medical News Today - Medical News Today (press release)

Sankyo's WelChol sees good patient data.(Sankyo Company Ltd.)(Brief …  -  Oct 17, 2005
A new study published in the September issue of Current Medical Research and Opinion demonstrated that the addition of WelChol (colesevelam HCl) to a stable ... Pay-Per-View - Pharma Marketletter - Factiva, from Dow Jones

… Filing of Supplemental New Drug Application for WelChol in the Tr  -  Jan 2, 2007
If approved, WelChol will be the first LDL cholesterol lowering medication ... Clinical studies have shown that WelChol lowers A1C in patients with type 2 ... Pay-Per-View - PR Newswire - HighBeam Research

WelChol Gains Type 2 Diabetes Indication  -  Jan 28, 2008
The FDA has approved Daiichi Sankyo's cholesterol treatment WelChol for the improvement of glycemic control in adults with Type 2 diabetes. ... FDA news - FDA news (subscription)

DIET, MEDICINES EASE DIARRHEA  -  Jan 13, 2006
Questran and WelChol, two cholesterol medicines, bind bile, and that can stop watery stools. The antacid Amphojel is another way to stop bile diarrhea. ... Pay-Per-View - South Florida Sun - Sentinel - ProQuest Archiver

Press Release: Welchol(TM) Lowered A1C by a Mean 1 Percent or …  -  May 30, 2008
Welchol(TM) Lowered A1C by a Mean 1 Percent or Greater When Added to Metformin-, Insulin-, or Sulfonylurea-Based Therapy in 47 Percent of Patients ... Pay-Per-View - PR Newswire - HighBeam Research

Press Release: New Study Demonstrates Colesevelam HCl Lowers Both …  -  Jun 23, 2007
WelChol effectively lowers LDL cholesterol (or "bad cholesterol ... the ... 2) Welchol is ... factors; elevated LDL cholesterol and blood glucose ... ... Pay-Per-View - PR Newswire - HighBeam Research

Daiichi launches Welchol.  -  Mar 17, 2008
Daiichi launches Welchol. PARSIPPANY, N.J. -- Daiichi Sankyo Inc. has received Food and Drug Administration approval of Welchol (colesevelam HCl) to improve ... $9.94 - Chain Drug Review - Alacra Store

Press Release: New Study Confirms WelChol Improves Glycemic Control …  -  Nov 15, 2006
New Study Confirms WelChol Improves Glycemic Control in Patients With Uncontrolled Type 2 Diabetes Mellitus on Insulin. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research

… Sankyo said the FDA has approved Welchol (colesevelam HCI)...  -  Mar 1, 2008
Daiichi Sankyo said the FDA has approved Welchol (colesevelam HCI) indicated to improve glycemic control in adults.(Pipeline) ... find Medical Marketing ... Pay-Per-View - Medical Marketing & Media - HighBeam Research

… : Branded Drugs)(Food and Drug Administration approves WelChol …  -  Feb 4, 2008
WelChol gets FDA OK(RX RETAIL PHARMACY: Branded Drugs)(Food and Drug Administration approves WelChol tablets )(Brief article) ... find Chain Drug Review ... Pay-Per-View - Chain Drug Review - HighBeam Research

New and generic drug approvals: WelChol Tablets.  -  Sep 12, 2006
On 12 Sep 2006, the US Food and Drug Administration announced approval of NDA 021176 (efficacy supplement with clinical data) for WelChol Tablets. ... Pay-Per-View - US Food and Drug Administration News - Factiva, from Dow Jones

… Release: MultiVu Video Feed: WELCHOL (R) (COLESEVELAM HCL) …  -  Jan 18, 2008
MultiVu Video Feed: WELCHOL (R) (COLESEVELAM HCL) RECEIVES FDA APPROVAL FOR GLUCOSE CONTROL IN ADULTS WITH TYPE 2 DIABETES MELITUS. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research

Article: Daiichi launches Welchol.(RX/DIABETES CARE) - Chain Drug …  -  Mar 17, 2008
Daiichi launches Welchol.(RX/DIABETES CARE) ... find Chain Drug Review articles. PARSIPPANY, NJ -- Daiichi Sankyo Inc. has received Food and Drug ... Pay-Per-View - Chain Drug Review - HighBeam Research

Welchol granted approval for glycemic control.  -  Feb 11, 2008
Welchol granted approval for glycemic control. Colesevelam (Welchol, Daiichi Sankyo) can now be used in adults with Type 2 diabetes to improve glycemic ... $9.94 - Drug Topics - Alacra Store

… Show Addition of a Bile Acid Sequestrant (WelChol, colesevelam...  -  Nov 15, 2005
First Data to Show Addition of a Bile Acid Sequestrant (WelChol, colesevelam HCl) to Statin Therapy Significantly Reduces Median hs-CRP Levels. from PR ... Pay-Per-View - PR Newswire - HighBeam Research

Press Release: First Clinical Trial to Demonstrate Colesevelam HCl...  -  Jun 10, 2006
WelChol treatment resulted in a mean 0.5% reduction in A1C versus placebo (p=0.007). Moreover, in patients with A1C greater than or equal to 8.0%, WelChol ... Pay-Per-View - PR Newswire - HighBeam Research

Colesevelam HCl Lowered LDL Cholesterol In Pediatric Patients With …  -  Nov 12, 2008
Welchol should not be used for the treatment of type 1 diabetes or diabetic ... Welchol has not been studied in type 2 diabetes as monotherapy or in ... Medical News Today - Medical News Today (press release)

Press Release: KineMed Evaluates the Mechanism of Action for …  -  May 21, 2007
IMPORTANT INFORMATION ABOUT WELCHOL (colesevelam HCl) Indications Welchol ... The safety of Welchol(R) (colesevelam HCl) has been established through an . ... Pay-Per-View - PR Newswire - HighBeam Research

Press Release: Colesevelam HCl Lowered LDL Cholesterol in Pediatric …  -  Nov 11, 2008
Welchol should not be used for the treatment of type 1 diabetes or diabetic ... Welchol has not been studied in type 2 diabetes as monotherapy or in ... Pay-Per-View - PR Newswire - HighBeam Research

New Discovery of Key Difference in Bile Acid Metabolism in Patients...  -  Jun 9, 2008
2) Colesevelam HCl is marketed in the US as Welchol(TM). ... Welchol is indicated as an adjunct to diet and exercise to reduce elevated low-density ... RedOrbit

Daiichi Sankyo, Inc. Data show addition of a bile acid sequestrant to...  -  May 15, 2006
This is the first data to demonstrate that WelChol, a bile acid sequestrant (BAS), ... The pooled study results also demonstrated that WelChol plus a statin ... Pay-Per-View - Biotech Week - Factiva, from Dow Jones

Colesevelam HCl Lowers A1C, LDL Cholesterol In Patients With …  -  Jun 25, 2007
WelChol (colesevelam HCl) is indicated for LDL-C lowering and was ... WelChol is the top-selling branded drug in the bile acid sequestrants (BAS) class. ... emaxhealth.com

Improving routes in API manufacturing: catalytic routes to producing ...  -  Jul 1, 2007
The production of colesevelam hydrochloride, the API in "WelChol" is an example of a successful ... WelChol is marketed by Genzyme Corporation's (Cambridge, ... Free with registration - Pharmaceutical Technology - AccessMyLibrary.com

Перечень показаний препарата WelChol® может быть увеличен  -  Jan 10, 2007
ЯпонÑ?каÑ? компаниÑ? Daiichi Sankyo Co., Ltd. намерена зарегиÑ?трировать в СШÐ? препарат WelChol® (Сolesevelam HCl) Ñ? новым показанием: длÑ? коррекции уровнÑ? ... ФармацевтичеÑ?кий веÑ?тник

Daiichi's Combination Therapy Found Effective Against Type 2 Diabetes  -  May 19, 2008
The efficacy of Welchol compared to placebo was evaluated in patients ... The addition of Welchol in patients on established metformin-based therapy ... RedOrbit

New Study Demonstrates Colesevelam HCl Lowers Both A1C And LDL …  -  Jun 23, 2007
WelChol (colesevelam HCl) is indicated for LDL-C lowering and was ... WelChol is the top-selling branded drug in the bile acid sequestrants (BAS) class. ... marketwire.com

… Show Addition of a Bile Acid Sequestrant (WelChol, colesevelam...  -  Apr 18, 2006
First Data to Show Addition of a Bile Acid Sequestrant (WelChol, colesevelam HCl) to Statin Therapy Significantly Reduces Median hs-CRP Levels. from PR ... Pay-Per-View - PR Newswire - HighBeam Research

Connecticut Trial Court Official Decisions - POLLETTA v. ESI MAIL …  -  May 10, 2005
The package, however, contained a drug known as Welchol intended for a patient by the name of Corrine Locust.[fn1] The plaintiff's wife opened the package, ... Pay-Per-View - Connecticut Trial Court Official... - Loislaw

… разрешило маркетинг противодиабетичеÑ?кого препарата Welchol  -  Jan 22, 2008
КомпаниÑ? Daiichi Sankyo, Inc., американÑ?кое подразделение Ñ?понÑ?кой фармкомпании Daiichi Sankyo Co., Ltd., получила разрешение УправлениÑ? по контролю за ... ФармацевтичеÑ?кий веÑ?тник

New drug combination further reduces cholesterol.  -  Apr 23, 2007
WelChol was approved in 2000 for the reduction of LDL, either alone or in ... The recent study revealed that WelChol (colesevelam HCl) combined with ezetim ... $9.94 - Drug Store News - Alacra Store

Approval for Adjunctive Drug to Treat Type 2 Diabetes  -  Apr 10, 2008
The FDA has approved Welchol (colesevelam hydrochloride) to reduce blood glucose ... Welchol can lower both hemoglobin A 1c and LDL levels in patients with ... Renal and Urology News

MM&M judging panel.(The Judges)  -  Nov 1, 2006
Anne Booth Dayton joined Daiichi Sankyo in 2002 as a senior product manager for WelChol. As director of the WelChol Franchise, she currently leads the ... Free with registration - Medical Marketing & Media - AccessMyLibrary.com

How Low Can Vytorin Go?  -  Apr 4, 2008
Christie Ballantyne of Houston's Baylor College of Medicine says he thinks using resin drugs like Questran or WelChol before Zetia doesn't make much sense, ... Forbes

Daiichi Sankyo Eyes Reentering Diabetes Treatment Field  -  Sep 14, 2006
After reestablishing its business of diabetes treatments with WelChol, ... WelChol (generic name: colesevelam hydrochloride) was discovered by Genzyme Corp. ... Pay-Per-View - Japan Chemical Week - Factiva, from Dow Jones

Article: Abbott investors shrug at drug report; Company defends...  -  Jun 5, 2007
Article: No significant interaction found when WelChol is coadministered ... WelChol (colesevelam HCI) was coadministered with TriCor (fenofibrate tablets). ... Pay-Per-View - Chicago Sun-Times - HighBeam Research

Press Release: Recent Findings from the Framingham Offspring Study …  -  Dec 13, 2007
Article: WelChol and Ezetimibe Combination Therapy Provides Significant ... ... Article: First Study to Evaluate WelChol/Ezetimibe and Simvastatin Effect . ... Pay-Per-View - PR Newswire - HighBeam Research

DAIICHI SANKYO BOLSTERING PHARMACEUTICAL BUSINESS IN US  -  Nov 19, 2007
In fiscal 2008, the subsidiary will hire around 200 more sales reps to promote broader applications for its cholesterol-lowering drug, WelChol. ... $4.95 - AsiaPulse News - ECNext

China One Corp acquires IND Lifetech Group Ltd - Dec 12, 2008 - Deal ...  -  Dec 12, 2008
WelChol, the number one product in the bile acid… DAIICHI SANKYO COMPANY, LIMITED-COMPANY INSIGHT · DAIICHI SANKYO COMPANY, LIMITED-COMPANY INSIGHT ... Pay-Per-View - deals - Alacra Store

Article: Crouching trainers, hidden horses - New Straits Times |...  -  Sep 4, 2007
PARSIPPANY, N.J., June 10 /PRNewswire/ -- The first data to demonstrate the effect of WelChol(R) (colesevelam hydrochloride) on glucose lowering was ... Pay-Per-View - New Straits Times - HighBeam Research

Daiichi Sankyo.(Update) | Article from Medical Marketing & Media | …  -  Dec 1, 2008
Article: Daiichi Sankyo said the FDA has approved Welchol ... ... GlaxoSmithKline/ Valeant anticonvulsant, and Daiichi Sankyo's Welchol, a cholesterol drug ... Pay-Per-View - Medical Marketing & Media - HighBeam Research

Colesevelam aids glycemic control.(Metabolic Disorders)  -  Aug 1, 2007
The bile acid sequestrant colesevelam HCl, sold under the name WelChol, has been approved in the United States for LDL cholesterol lowering since 2000. ... Free with registration - Family Practice News - AccessMyLibrary.com

Japam's Daiichi Sankyo quietly expanding in the USA as others...  -  Oct 15, 2007
As well as Azor, over the next several months, the company expects to launch a type 2 diabetes indication for its lipid-lowering drug, WelChol (colesevalam ... Free with registration - Pharma Marketletter - AccessMyLibrary.com

US Subsidiaries Join Together to Form Daiichi Sankyo, Inc.  -  Apr 3, 2006
BENICAR(R) HCT (olmesartan medoxomil-hydrochlorothiazide), WelChol(R) (colesevelam HCl), ... visit http://www.benicar.com/, http://www.welchol.com/, ... $4.95 - PR Newswire - ECNext

Daiichi Sankyo Quietly Grows While Other Pharmaceutical Firms …  -  Oct 1, 2007
In the next several months, the company expects to launch a type 2 diabetes indication for its lipid-lowering drug, WelChol(R) (colesevalam hydrochloride). ... $4.95 - PR Newswire - ECNext

Press Release: US Subsidiaries Join Together to Form Daiichi Sankyo, ...  -  Apr 3, 2006
BENICAR(R) HCT (olmesartan medoxomil-hydrochlorothiazide), WelChol(R) (colesevelam HCl), ... visit http://www.benicar.com/, http://www.welchol.com/, ... Pay-Per-View - PR Newswire - HighBeam Research

Factiva Search  -  Jan 2, 2007
Daiichi Sankyo files supplemental NDA for WelChol. 02 January, 2007 Datamonitor News and Comment. Daiichi Sankyo Inc has filed a supplemental new drug ... Pay-Per-View - Datamonitor News and Comment - Factiva, from Dow Jones

Article: Colesevelam aids glycemic control.(Metabolic Disorders) -...  -  Aug 1, 2007
The bile acid sequestrant colesevelam HCl, sold under the name WelChol, has been approved in the United States for LDL cholesterol lowering since 2000. ... Pay-Per-View - Family Practice News - HighBeam Research

Japan stock market week to Jan 8, 2007  -  Jan 9, 2007
Daiichi Sankyo remained unchanged, despite its filing of a supplemental New Drug Application with the US Food and Drug Administration for WelChol ... Pay-Per-View - Pharma Marketletter - Factiva, from Dow Jones

Article: Elderly See Cholesterol Levels Fall - AP Online | HighBeam …  -  Oct 12, 2005
Article: WelChol(R), in Combination With Lipitor(R), Cuts LDL ... PR Newswire; December 27, 2001 ; 700+ words ... ... combination, can lower LDL cholesterol ... Pay-Per-View - AP Online - HighBeam Research

Study: Statins Prevents Heart Attacks Up to a Decade after Use  -  Oct 12, 2007
...study was partly funded by Bristol-Myers Squibb Co., the maker of Pravachol, and Daiichi Sankyo Inc., maker of the bile acid sequestrant WelChol. ... FOXNews

Article: Peter Lawrence and Colin Thirtle (eds): (2001) Africa and...  -  Feb 1, 2005
ANNE BOOTH DAYTON Senior product manager for Welchol, Sankyo Pharma Speaking at the CIB's "CRM for the Pharmaceutical Industry" conference in New York Anne ... Pay-Per-View - Journal of Asian and African Studies - HighBeam Research

Article: Atherosclerosis; Treatment. - NWHRC Health Center - …  -  Mar 16, 2005
Article: WelChol(R), in Combination With Lipitor(R), Cuts LDL ... PR Newswire; December 27, 2001 ; 700+ words ... ... combination, can lower LDL cholesterol ... Pay-Per-View - NWHRC Health Center - Atherosclerosis - HighBeam Research

Treating High Cholesterol  -  Aug 6, 2008
Resin drugs include WelChol, Prevalite and Locholest. The first medication in the selective cholesterol absorption inhibitor class, called Zetia, ... FOXNews

Press Release: Abbott Statement on FIELD Study Presented at American ...  -  Nov 14, 2005
Article: New Study Demonstrates Co-Administration of WelChol(R) ... PR Newswire; October 15, 2004 ; 700+ words ... ... colesevelam HCI) was co-administered ... Pay-Per-View - PR Newswire - HighBeam Research

Daiichi–Sankyo раÑ?ширÑ?ет деÑ?тельноÑ?ть в СШÐ?  -  Nov 22, 2007
ПланируетÑ?Ñ? Ñ?оздать еще около 200 рабочих меÑ?Ñ‚ длÑ? продвижениÑ? на американÑ?ком рынке гипохолеÑ?теринемичеÑ?кого препарата WelChol (colesevalem). ... ФармацевтичеÑ?кий веÑ?тник

High blood cholesterol  -  Aug 6, 2008
The medications cholestyramine (Prevalite, Questran), colesevelam (Welchol) and colestipol (Colestid) lower cholesterol indirectly by binding to bile acids. ... CNN International

Technology: Corporate Videogames | Newsweek Small Business | …  -  Aug 11, 2008
The Japanese pharmaceutical company entered the gaming realm in the summer of 2007, just prior to re-purposing its cholesterol drug Welchol for treatment of ... Newsweek

Gen Y's Corporate Games  -  Aug 6, 2008
The Japanese pharmaceutical company entered the gaming realm in the summer of 2007, just prior to re-purposing its cholesterol drug Welchol for treatment of ... Forbes

Daiichi Sankyo plans major US expansion  -  Feb 14, 2007
It also hopes to gain approval for its cholesterol-lowering drug Welchol also to be used to treat diabetes. Daiichi Sankyo, however, cut its operating ... Reuters

Health for Life MD | Newsweek Health for Life MD | Newsweek.com  -  Jul 3, 2008
The possibilities include ezetimibe (Zetia), the fibrates (Tricor and Lopid) and the resins (WelChol, Questran, and others). Niacin is also very helpful; ... Newsweek

Companies, People, Ideas  -  Feb 11, 2008
Successful drugs include Benicar, a small-selling cholesterol drug called Welchol and a new blood pressure pill called Azor. ... Forbes

Lowering cholesterol without statin drugs  -  Oct 6, 2008
Other non-statin drugs include Colestid, Tricor and WelChol. Fish oil can reduce LDL cholesterol and triglycerides. I am seeing a new guy. ... Los Angeles Times

Gradeons: Medicare drug costs going up in 2009 | Life | Chron.com - …  -  Oct 12, 2008
Other nonstatin drugs include Colestid, Tricor and WelChol. Fish oil can reduce both LDL cholesterol and triglycerides. ... Houston Chronicle

Press Release: New Discovery of Key Difference in Bile Acid Metabolism...  -  Jun 9, 2008
2) Colesevelam HCl is marketed in the U.S. as Welchol(TM). ... Article: Daiichi Sankyo, Inc. Announces Filing For WelChol ... PR Newswire; March 28, ... Pay-Per-View - PR Newswire - HighBeam Research

China to host FDA outpost.(RX RETAIL PHARMACY: Government)(Brief …  -  Oct 27, 2008
Article: WelChol gets FDA O.K.(RX RETAIL PHARMACY: Branded Drugs)(Food and . ... The Food and Drug Administration has approved WelChol tablets as an adjunct ... Pay-Per-View - Chain Drug Review - HighBeam Research

Article: Medicines Co. gets FDA OK for injectable BP treatment.(RXs) ...  -  Aug 18, 2008
Article: WelChol gets FDA O.K.(RX RETAIL PHARMACY: Branded ... ... The Food and Drug Administration has approved WelChol tablets as an adjunct treatment to ... Pay-Per-View - Chain Drug Review - HighBeam Research

Press Release: VAP(R) Cholesterol Test Helps Researchers Identify …  -  Nov 10, 2008
Article: New Study Finds Additional LDL-C Drops When WelChol(R) ... PR Newswire; October 5, 2005 ; 700+ words ... ... TriCor(R)(1)) in patients with mixed ... Pay-Per-View - PR Newswire - HighBeam Research

Article: Hyperlipidemia in children and teens.(Clinical Guidelines...  -  Feb 15, 2008
Article: WelChol(R), in Combination With Lipitor(R), Cuts LDL ... PR Newswire; December 27, 2001 ; 700+ words ... ... combination, can lower LDL cholesterol ... Pay-Per-View - Family Practice News - HighBeam Research

Article: Simvastatin-amiodarone interaction risky, FDA FDA warns.(NEWS...  -  Sep 1, 2008
Article: First Study to Evaluate WelChol/Ezetimibe and Simvastatin ... PR Newswire; November 13, 2006 ; 700+ words . ... Pay-Per-View - Internal Medicine News - HighBeam Research

Article: Fed: Cholesterol-lowering drugs an option for all diabetics ...  -  Jan 11, 2008
Article: First Data to Show Addition of a Bile Acid Sequestrant (WelChol, ... PR Newswire; November 15, 2005 ; 700+ words ... ... when added to statin ... Pay-Per-View - AAP General News - HighBeam Research

Article: Desonate promotion.(Branded Drugs)(Brief article) - Chain...  -  Nov 20, 2006
Article: WelChol gets FDA O.K.(RX RETAIL PHARMACY: Branded ... ... The Food and Drug Administration has approved WelChol tablets as an adjunct treatment to ... Pay-Per-View - Chain Drug Review - HighBeam Research





Health Home | Conditions | Cancer | Medications | Surgery | Vaccines


The Cancer News Network


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.



COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy